All Clinical & Diagnostics articles – Page 4
-
NewsPortable TB test matches lab accuracy in just minutes
A portable device called MiniDock MTB can deliver accurate TB test results in less than half an hour. Researchers show the device is as effective as a laboratory test and can detect cases even among people who have trouble producing phlegm samples from deep within their lungs.
-
NewsPhage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine
The Targeting Phage Therapy 2026 Congress will bring together leading scientists, clinicians, microbiologists, engineers, biotech leaders, regulators, hospital teams, start-ups, and innovators to ask: How can phage therapy move from promising science to accessible, validated, and deployable medicine?
-
NewsCOVID-19 and severe heart attack increase mortality by 25% after one year, more than double pre-pandemic rates
Findings from the North American COVID-19 Myocardial Infarction (NACMI) registry demonstrate significantly higher one-year mortality rates in patients with COVID-19 and ST-elevation myocardial infarction (STEMI) compared to patients with STEMI alone.
-
NewsCinnamic acid blocks plasmid conjugation to slow antibiotic resistance spread
A new study reveals that cinnamic acid, a widely used food additive found in cinnamon, can effectively inhibit plasmid‑mediated conjugation, a major route for the global spread of antibiotic resistance genes (ARGs).
-
NewsIntestinal Candida albicans is associated with subclinical coronary atherosclerosis in metabolic dysfunction-associated steatotic liver disease with cirrhosis
Researchers have published the first report of gut fungal dysbiosis associated with the severity of metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis. An increased abundance of fecal C. albicans was observed in patients with cirrhosis and high SCA burden.
-
NewsEight-year results from two randomized phase 3 trials of tenofovir alafenamide for chronic hepatitis B virus infection in China
Tenofovir alafenamide (TAF) has demonstrated comparable efficacy to tenofovir disoproxil fumarate (TDF), with improved renal and bone safety, in Chinese participants with chronic hepatitis B enrolled in two Phase 3 trials.
-
NewsCOVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.
-
NewsIBS treatment response predicted by gut microbiome in new study
Researchers investigating irritable bowel syndrome with diarrhea observed distinct characteristics of patients’ gut microbiomes that predicted whether they responded to the low FODMAP diet or rifaximin — or did not respond to treatment.
-
NewsResearchers combine polarized light and a magnetic field to spot malaria under the microscope
Researchers have developed a new microscopy method that uses a magnetic field and polarized light to provide quantitative measurements that could enable faster and more objective detection of malaria in blood.
-
NewsGut microbiome changes may signal Parkinson’s disease risk
Scientists have found that people with Parkinson’s disease have a distinctive makeup of gut microbes, as do healthy individuals who are genetically at risk of Parkinson’s disease. This could help to develop tests to reveal a person’s risk of developing Parkinson’s disease.
-
NewsOral-gut axis points to salivary biomarkers for early gastric cancer detection
A recent study has identified distinct microbial “signatures” within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric cancer (GC). Research shows how specific lactic acid-producing bacteria (LAB) migrate from the mouth to colonize the gastrointestinal tract.
-
NewsNew biosensor for detecting active tuberculosis
A research team is developing a sensor that paves the way for the rapid, selective and cost-effective detection of active tuberculosis. The device detects the presence of a protein secreted by Mycobacterium tuberculosis, the bacterium that causes the disease.
-
NewsThe cold virus ‘hides’ and multiplies in the tonsils and adenoids, even in people without symptoms
A study reveals that tissues such as the tonsils and adenoids can serve as hiding places for the rhinovirus, which causes the common cold. The pathogen can persist in these tissues for long periods, be transmitted unexpectedly, and trigger new outbreaks of the disease.
-
NewsStudy finds blood pressure drug effective for treating antibiotic-resistant bacteria
A new study reports that a drug used to lower blood pressure could also be the basis of a promising new treatment for methicillin-resistant Staphylococcus aureus (MRSA). Candesartan cilexetil not only killed MRSA bacteria at different growth stages, but also reduced the formation of biofilms.
-
NewsLong-term cure rates for multidrug-resistant tuberculosis much better than expected
A new national cohort study from Latvia provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The study shows that long-term disease-free survival rates are significantly higher than previous standard indicators suggest.
-
FeaturesClinical considerations for the next pandemic: challenges facing Japan and strategic preparedness
Multiple global pandemics over the past century – the Spanish influenza (1918), Asian influenza (1957), Hong Kong influenza (1968), H1N1 influenza (2009), and COVID‑19 (since 2019) – have increasingly underscored the necessity for healthcare systems worldwide to be resilient, rapidly responsive, and forward‑facing.
-
NewsColor test ‘sniffs out’ dangerous staph strains fast
Researchers have developed a rapid colour-changing test that can distinguish between different strains of golden staph, including those likely to be virulent and antibiotic resistant.
-
NewsGlobal strategy to combat drug‑resistant fungi is about to change
An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world are calling for action against drug‑resistant fungi.
-
NewsUltrasensitive test reveals evidence of previously undetected tuberculosis in Boston Hospital patients
Researchers have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) in patients hospitalized in Boston, suggesting that tuberculosis disease may be significantly underdiagnosed in the United States.
-
NewsShorter antibiotic courses show similar outcomes to longer use for some pneumonia patients
A multicenter target trial emulation found that for eligible patients hospitalized with community-acquired pneumonia (CAP), health outcomes were similar whether they received a three- to four-day course of antibiotics or a course lasting five days or more.